These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19076216)

  • 1. Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events.
    Apolloni S; Montilli C; Finocchi P; Amadio S
    FEBS J; 2009 Jan; 276(2):354-64. PubMed ID: 19076216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinergic signalling and disorders of the central nervous system.
    Burnstock G
    Nat Rev Drug Discov; 2008 Jul; 7(7):575-90. PubMed ID: 18591979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis.
    Amadio S; Apolloni S; D'Ambrosi N; Volonté C
    J Neurochem; 2011 Mar; 116(5):796-805. PubMed ID: 21214557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of P2 receptors in the growth and survival of neurons in the CNS.
    Franke H; Illes P
    Pharmacol Ther; 2006 Mar; 109(3):297-324. PubMed ID: 16102837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane compartments and purinergic signalling: occurrence and function of P2X receptors in lung.
    Barth K; Kasper M
    FEBS J; 2009 Jan; 276(2):341-53. PubMed ID: 19076210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purinergic signalling: from normal behaviour to pathological brain function.
    Burnstock G; Krügel U; Abbracchio MP; Illes P
    Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses.
    Köles L; Furst S; Illes P
    Drug News Perspect; 2005 Mar; 18(2):85-101. PubMed ID: 15883618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiological roles of P2 receptors in glial cells.
    Abbracchio MP; Verderio C
    Novartis Found Symp; 2006; 276():91-103; discussion 103-12, 275-81. PubMed ID: 16805425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic signalling--an overview.
    Burnstock G
    Novartis Found Symp; 2006; 276():26-48; discussion 48-57, 275-81. PubMed ID: 16805422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future.
    Burnstock G
    Bioessays; 2012 Mar; 34(3):218-25. PubMed ID: 22237698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
    Burnstock G
    Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP and the pathogenesis of COPD.
    Mortaz E; Folkerts G; Nijkamp FP; Henricks PA
    Eur J Pharmacol; 2010 Jul; 638(1-3):1-4. PubMed ID: 20423711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2 receptor signalling, proliferation of astrocytes, and expression of molecules involved in cell-cell interactions.
    Neary JT; Kang Y; Shi YF; Tran MD; Wanner IB
    Novartis Found Symp; 2006; 276():131-43; discussion 143-7, 233-7, 275-81. PubMed ID: 16805427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinergic contribution to amyotrophic lateral sclerosis.
    Volonté C; Apolloni S; Parisi C; Amadio S
    Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2X receptors and synaptic plasticity.
    Pankratov Y; Lalo U; Krishtal OA; Verkhratsky A
    Neuroscience; 2009 Jan; 158(1):137-48. PubMed ID: 18495357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular physiology of P2X receptors and ATP signalling at synapses.
    Khakh BS
    Nat Rev Neurosci; 2001 Mar; 2(3):165-74. PubMed ID: 11256077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of P2X receptor mediated currents in astrocytes and GluR type glial cells of the hippocampal CA1 region.
    Jabs R; Matthias K; Grote A; Grauer M; Seifert G; Steinhäuser C
    Glia; 2007 Dec; 55(16):1648-55. PubMed ID: 17849469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALS: focus on purinergic signalling.
    Volonté C; Apolloni S; Carrì MT; D'Ambrosi N
    Pharmacol Ther; 2011 Oct; 132(1):111-22. PubMed ID: 21704075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters.
    Volonté C; D'Ambrosi N
    FEBS J; 2009 Jan; 276(2):318-29. PubMed ID: 19076212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.